why choose us

First received: May 25, 2023

Clinical Trial: A Study to Assess the Effects of Fluvoxamine on Savolitinib Exposure in Healthy Male Subjects

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Healthy Male Subjects

Study Type: INTERVENTIONAL


Official Title: A Phase I, Open-label, Fixed-sequence Study to Assess the Effects of Strong CYP1A2 Inhibitor (Fluvoxamine) on Savolitinib Exposure in Healthy Male Subjects

Brief Summary: This study will assess the effects of strong CYP1A2 (Cytochrome P450 1A2) inhibitor (fluvoxamine) on savolitinib exposure in healthy male subjects, performed at a single clinical unit.

Read more